| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ANIE.201105901 |
| P698 | PubMed publication ID | 22095772 |
| P50 | author | Gisbert Schneider | Q51615601 |
| Petra Schneider | Q110029671 | ||
| P2093 | author name string | Zoe Waibler | |
| Stefanie Bauer | |||
| Jan A Hiss | |||
| Karl-Heinz Altmann | |||
| Bernhard Pfeiffer | |||
| Michael Reutlinger | |||
| Tim Geppert | |||
| Martin Weisel | |||
| Elea Conrad | |||
| P2860 | cites work | The Protein Data Bank | Q24515306 |
| Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons | Q27671836 | ||
| The three-dimensional high resolution structure of human interferon alpha-2a determined by heteronuclear NMR spectroscopy in solution | Q27748770 | ||
| The overlap of small molecule and protein binding sites within families of protein structures | Q28472769 | ||
| Inhibitors of Helicobacter pylori protease HtrA found by 'virtual ligand' screening combat bacterial invasion of epithelia | Q28477589 | ||
| Ligand efficiency: a useful metric for lead selection | Q29617403 | ||
| PocketPicker: analysis of ligand binding-sites with shape descriptors. | Q30364721 | ||
| Spatial chemical conservation of hot spot interactions in protein-protein complexes | Q33302062 | ||
| Small molecular weight protein-protein interaction antagonists: an insurmountable challenge? | Q33337530 | ||
| Fragment-Based Drug Design | Q33730346 | ||
| The type I interferon receptor: structure, function, and evolution of a family business. | Q33765617 | ||
| Biophysical analysis of the interaction of human ifnar2 expressed in E. coli with IFNalpha2. | Q33862977 | ||
| ANCHOR: a web server and database for analysis of protein-protein interaction binding pockets for drug discovery | Q33957616 | ||
| Autoimmune disease complicating antiviral therapy for hepatitis C virus infection | Q35045126 | ||
| Induction and regulation of IFNs during viral infections | Q35867540 | ||
| Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance | Q36426325 | ||
| Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex | Q36458100 | ||
| Targeting protein-protein interactions with small molecules: challenges and perspectives for computational binding epitope detection and ligand finding | Q36611966 | ||
| Type I interferon as a stimulus for cross-priming | Q37027815 | ||
| Endogenous type I interferon inducers in autoimmune diseases | Q37610432 | ||
| Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host | Q37721131 | ||
| Structural biology in fragment-based drug design | Q37752790 | ||
| HotPoint: hot spot prediction server for protein interfaces | Q38373749 | ||
| Matrix protein mediated shutdown of host cell metabolism limits vesicular stomatitis virus-induced interferon-alpha responses to plasmacytoid dendritic cells | Q40034481 | ||
| Thogoto virus infection induces sustained type I interferon responses that depend on RIG-I-like helicase signaling of conventional dendritic cells | Q42142515 | ||
| Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses | Q42910554 | ||
| Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation | Q43987901 | ||
| Context-based identification of protein-protein interfaces and "hot-spot" residues. | Q51585524 | ||
| Side-chain flexibility in proteins upon ligand binding. | Q52080522 | ||
| Excessive CpG 1668 stimulation triggers IL-10 production by cDC that inhibits IFN-α responses by pDC | Q57339899 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | protein-protein interaction | Q896177 |
| virtual screening | Q4112105 | ||
| P304 | page(s) | 258-261 | |
| P577 | publication date | 2011-11-16 | |
| P1433 | published in | Angewandte Chemie International Edition | Q62023953 |
| P1476 | title | Immunosuppressive small molecule discovered by structure-based virtual screening for inhibitors of protein-protein interactions | |
| P478 | volume | 51 |
| Q50243911 | A metal-based inhibitor of tumor necrosis factor-α. |
| Q34331745 | Does chemistry have a future in therapeutic innovations? |
| Q58697064 | Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery |
| Q35214824 | Hierarchical virtual screening approaches in small molecule drug discovery |
| Q34135430 | In silico identification of an interferon inhibitor |
| Q34481459 | Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions |
| Q27674529 | Small-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1α |
| Q35738960 | State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors |
| Q35103944 | Structure-based design of small-molecule protein-protein interaction modulators: the story so far. |
Search more.